ArticleThe Lancet. Rheumatology2021

Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trial.

Arthur G Pratt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.